Brief: Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial Of Oral Fadraciclib

Bio Green Med Solution

26/10/2022 14:33

Oct 26 (Reuters) - Cyclacel Pharmaceuticals Inc
 CYCC.O :
    * CYCLACEL REPORTS PRELIMINARY DATA FROM ITS PHASE 1/2
CLINICAL
TRIAL OF ORAL FADRACICLIB IN PATIENTS WITH SOLID TUMORS AND
LYMPHOMA AT ENA 2022
    * CYCLACEL REPORTS PRELIMINARY DATA FROM ITS PHASE 1/2
CLINICAL
TRIAL OF ORAL FADRACICLIB IN PATIENTS WITH SOLID TUMORS AND
LYMPHOMA AT ENA 2022

Source text for Eikon:  ID:nGNXbQmFDV 
Further company coverage:  CYCC.O 
 ((Reuters.Briefs@thomsonreuters.com;))